72517-23-8 Usage
General Description
5-Bromo-2,3-dimethoxy benzoic acid is a chemical compound with the molecular formula C9H9BrO4. It is a derivative of benzoic acid, which is commonly used in organic synthesis. 5-BROMO-2,3-DIMETHOXY-BENZOIC ACID contains a bromine atom and two methoxy groups attached to the benzene ring. It is a white to off-white crystalline powder that is sparingly soluble in water but more soluble in organic solvents. 5-BROMO-2,3-DIMETHOXY-BENZOIC ACID has potential applications in the pharmaceutical industry and in organic synthesis as a building block for more complex molecules. It is important to handle this compound with care and use appropriate safety precautions due to its potential hazards.
Check Digit Verification of cas no
The CAS Registry Mumber 72517-23-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,2,5,1 and 7 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 72517-23:
(7*7)+(6*2)+(5*5)+(4*1)+(3*7)+(2*2)+(1*3)=118
118 % 10 = 8
So 72517-23-8 is a valid CAS Registry Number.
InChI:InChI=1/C9H9BrO4/c1-13-7-4-5(10)3-6(9(11)12)8(7)14-2/h3-4H,1-2H3,(H,11,12)
72517-23-8Relevant articles and documents
Design, Synthesis, and Biological Evaluation of Quercetagetin Analogues as JNK1 Inhibitors
Hierold, Judith,Baek, Sohee,Rieger, Rene,Lim, Tae-Gyu,Zakpur, Saman,Arciniega, Marcelino,Lee, Ki Won,Huber, Robert,Tietze, Lutz F.
, p. 16887 - 16894 (2015/11/16)
The recent discovery of c-Jun NH2-terminal kinase JNK1 suppression by natural quercetagetin (1) is a promising lead for the development of novel anticancer agents. Using both X-ray structure and docking analyses we predicted that 5′-hydroxy- (2
Synthesis of 3-(5-bromo-2,3-dimethoxy-phenyl)-[1, 2, 4] oxadiazole analogues and their evaluation as anti-Parkinson's agents
Tiwari, Shashi B.,Kohli
, p. 386 - 398 (2008/12/22)
A series of 3-(5-bromo-2,3-dimethoxy-phenyl)-[1, 2, 4] oxadiazole derivatives was prepared and their evaluation for anti-Parkinson's activity was measured in vivo using albino rats. The result of the biological activity studies indicated that some of the
Design and synthesis of 99mTc-labeled benzamides dopamine D2/D3 receptor imaging agents
Jia, F.,Liu, B. L.,Liu, Z. H.
, p. S547 - S549 (2007/10/03)
-